Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. [electronic resource]
Producer: 20081210Description: 1166-72 p. digitalISSN:- 1474-5488
- Administration, Oral
- Adverse Drug Reaction Reporting Systems
- Antineoplastic Agents -- administration & dosage
- Bone Density Conservation Agents -- adverse effects
- Diphosphonates -- administration & dosage
- Drug Approval
- Female
- Humans
- Imidazoles -- adverse effects
- Incidence
- Infusions, Intravenous
- Jaw -- drug effects
- Male
- Osteonecrosis -- chemically induced
- Pamidronate
- Precipitating Factors
- Tooth Extraction
- United States -- epidemiology
- United States Food and Drug Administration
- Zoledronic Acid
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
There are no comments on this title.
Log in to your account to post a comment.